KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Other Accumulated Expenses (2017 - 2025)

Moderna (MRNA) has disclosed Other Accumulated Expenses for 9 consecutive years, with $185.0 million as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses fell 16.29% to $185.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $185.0 million through Dec 2025, down 16.29% year-over-year, with the annual reading at $185.0 million for FY2025, 16.29% down from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $185.0 million at Moderna, up from $73.0 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $613.0 million in Q2 2021, with the low at $42.0 million in Q2 2024.
  • Average Other Accumulated Expenses over 5 years is $236.5 million, with a median of $223.0 million recorded in 2021.
  • The sharpest move saw Other Accumulated Expenses surged 7213.29% in 2021, then tumbled 82.2% in 2024.
  • Over 5 years, Other Accumulated Expenses stood at $225.0 million in 2021, then increased by 10.67% to $249.0 million in 2022, then tumbled by 48.19% to $129.0 million in 2023, then soared by 71.32% to $221.0 million in 2024, then fell by 16.29% to $185.0 million in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $185.0 million, $73.0 million, and $192.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.